Clinical Trial

Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss

Study acronym: AUDIOGENAGE
Recruiting
View on ClinicalTrials.gov →
Summary
Age-related hearing loss, or presbycusis, is caused by many genetic and environmental factors. Its prevalence poses a public health challenge of early identification and effective hearing aid treatment. However, the lack of screening and of a validated audiological test battery to diagnose an individual's needs and to guide hearing aid adjustments is a major obstacle. Furthermore, monogenic forms of hearing loss affect only one functional module of hearing. The audiological test(s) dependent on the function of this module are affected, in a progressive manner, but not the others. A previous study showed that in early onset presbycusis patients, a quarter of the subjects tested were affected by monogenic presbycusis. The collection of audiological and vestibular tests, carried out on proven monogenic presbycusis patients and compared to that of normal hearing patients, would constitute a battery of tests allowing a precision diagnosis, then developed to all forms of presbycusis in order to study if the identification of abnormal functional modules can usefully guide the diagnosis and the early fitting.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-03-28; most recent amendment 2025-02-28.
Status change: Not Yet Recruiting → Recruiting 2022-08-16
Trial Details
NCT Number NCT05312983
Lead Sponsor Institut Pasteur
Collaborators: CEntre de Recherche et d'Innovation en Audiologie Humaine, Laboratoire de correction auditive
Conditions Presbyacusis
Enrollment 700 participants
Start Date 2022-07-28
Primary Completion 2027-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-03